Inventor
JEAN XU
Inventor
US
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes38%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C12NMicroorganisms or enzymes24%
C07DHeterocyclic compounds14%
PatentTitleYear
12,558,378Methods for lowering blood glucose202612,441,985Methods for making insulin in vivo202512,343,346Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same202511,890,304Pancreatic endocrine cells and methods thereof202411,708,562Differentiation of human embryonic stem cells202311,629,153Forms and compositions of a MK2 inhibitor202311,369,642Methods for lowering blood glucose202211,241,439Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to JANSSEN BIOTECH INC (5)· patent assignee history
2022–2025Patents assigned to CELGENE CORP (2)· patent assignee history
2022–2026Based in US· patent location history
2023Patents assigned to CELGENE CAR LLC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| JANSSEN BIOTECH INC | 5 | 2022–2026 |
| CELGENE CORP | 2 | 2022–2025 |
| CELGENE CAR LLC | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 8 | 2022–2026 |